The extracellular matrix: a new turn-of-the-screw for anti-angiogenic strategies. (Q44492980)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12829014%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

The extracellular matrix: a new turn-of-the-screw for anti-angiogenic strategies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12829014%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

main subject

extracellular matrix

0 references

angiogenesis inhibitor

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12829014%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Laura Sanz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12829014%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 June 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12829014%20AND%20SRC:MED&resulttype=core&format=json

Trends in Molecular Medicine

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12829014%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12829014%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12829014%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

256-262

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12829014%20AND%20SRC:MED&resulttype=core&format=json

Mechanisms of angiogenesis and arteriogenesis

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

Angiogenesis in cancer and other diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

Quantitative angiogenesis assays: Progress and problems

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

Vascular-specific growth factors and blood vessel formation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

Clinical applications of angiogenic growth factors and their inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

Tumor angiogenesis: past, present and the near future

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

Low plasma levels of matrix metalloproteinase 9 permit increased tumor angiogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

Matrix Metalloproteinase Inhibitors and Cancer--Trials and Tribulations

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

Strategies for MMP inhibition in cancer: innovations for the post-trial era.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

Alpha v integrins as receptors for tumor targeting by circulating ligands.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

Tumor regression by targeted gene delivery to the neovasculature

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

Integrin-mediated death: an explanation of the integrin-knockout phenotype?

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

A reevaluation of integrins as regulators of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

β1 Integrin Is Essential for Teratoma Growth and Angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

The alpha(1)beta(1) and alpha(2)beta(1) integrins provide critical support for vascular endothelial growth factor signaling, endothelial cell migration, and tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

Interaction of endostatin with integrins implicated in angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

Tumstatin, an endothelial cell-specific inhibitor of protein synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

Unfulfilled promise of endostatin in a gene therapy-xenotransplant model of human acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

Clinical translation of angiogenesis inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

Vasculogenic mimicry: how convincing, how novel, and how significant?

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

Basement membranes: Putting up the barriers

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

Genes expressed in human tumor endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

Enhancement of the antitumor activity of interleukin-12 by targeted delivery to neovasculature.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

Regulation of endothelial cell morphogenesis by integrins, mechanical forces, and matrix guidance pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

Identification of Cell Binding Sequences in Mouse Laminin γ1 Chain by Systematic Peptide Screening

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

Making antibodies by phage display technology

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

Generation and characterization of recombinant human antibodies specific for native laminin epitopes: potential application in cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

Single-chain antibody-based gene therapy: inhibition of tumor growth by in situ production of phage-derived human antibody fragments blocking functionally active sites of cell-associated matrices

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

Genetic approaches for antigen-selective cell therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

Generation of non-permissive basement membranes by anti-laminin antibody fragments produced by matrix-embedded gene-modified cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

A novel cell binding site in the coiled-coil domain of laminin involved in capillary morphogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

Development of a computer-assisted high-throughput screening platform for anti-angiogenic testing

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900070-4

7 January 2021

10.1016/S1471-4914(03)00070-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12829014%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12829014%20AND%20SRC:MED&resulttype=core&format=json